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rIgE switching requires the prior induction of Ce
ermline transcripts which is mediated by the con-
erted binding of STAT-6 and NFkB to the Ce pro-
oter. These transcription factors are regulated by
L-4 and CD40, respectively. However the latter can
ffect other signaling pathways and the present study
xplores the role of p38 MAPK in induction of Ce germ-
ine transcripts. CD40 and IL-4, both alone and in syn-
rgy, were initially shown to activate the Ce promoter
n a B cell lymphoma cell line. Under the same condi-
ions CD40 caused activation of p38 MAPK, whereas
L-4 was ineffective. The p38 MAPK inhibitor,
B203580, and a dominant negative form of p38 MAPK
ecreased the CD40 activation of the Ce promoter by
educing the ability of CD40 to increase the transacti-
ation potential of NFkB. This study suggests that p38
APK is crucially important in mediating CD40 acti-
ation of NFkB which acts to induce Ce germline tran-
cripts, ultimately facilitating IgE switching. © 2001
cademic Press
Key Words: CD40; IgE; isotype switching; allergy; p38
AP kinase; NFkB.
IgE is a central player in the generation of allergic
iseases and thus the molecular mechanisms underly-
ng IgE synthesis have become an area of intense in-
erest (reviewed in 1). In order for a B lymphocyte to
roduce IgE, it needs to undergo a process known as
sotype switching. This phenomenon involves the re-
ombination of the VDJ gene region to a different
eavy chain C (CH) gene which will thus encode for
nother heavy chain isotype with different effector
unctions but with the same antigen-binding specificity
2). Such recombination takes place between the 59
ntronic segment, known as the switch (S) region, of the
m gene and the corresponding S region of the appro-
riate CH gene (3). In the case of switching to IgE,
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ll rights of reproduction in any form reserved.ion, with deletion of the intervening DNA. However a
ecessary pre-requisite for this deletional recombina-
ion is the prior transcription of the Ce gene which
tarts at the Ie exon, upstream of the Se region, and
ontinues through the S region and Ce gene (4). The S
egion is removed by splicing, resulting in the joining of
he Ie exon and Ce region which together form a germ-
ine sterile transcript (5). The induction of these Ce
ermline transcripts is a determining step in isotype
witching to IgE since transcription through the Ce
ene segment makes that region accessible to switch
ecombination (6). The induction of Ce germline tran-
cripts is regulated by a promoter region, upstream of
he Ie exon, and it is activated by the concerted binding
f the transcription factors STAT-6 and NFkB (7–9).
L-4 regulates the activation of STAT-6 and the impor-
ance of this pathway in IgE synthesis is emphasised
y the lack of IgE switching in mice deficient for
TAT-6 (10). The engagement of the B cell transmem-
rane protein CD40 by its cognate ligand is sufficient
o cause activation of NF-kB (8, 11) and this synergises
ith STAT-6 to activate the Ce promoter (8, 9). The
rucial contribution of CD40 activation of NF-kB to IgE
ynthesis is reinforced by the observation that CD40
igand-deficient patients (12), CD40 deficient mice (13)
nd NF-kB deficient mice (14) are all defective in IgE
sotype switching and lack serum IgE. However the
ctivation of NF-kB may not be the sole contributory
athway to mediating IgE switching in response to
D40. The engagement of the latter has also been
hown to activate a plethora of intracellular signaling
olecules including protein tyrosine kinases and PI-3
inase (15). In addition much recent interest has fo-
ussed on the ability of CD40 to activate the mitogen-
ctivated protein kinases (MAPKs), especially the
-jun N-terminal kinase/stress-activated protein ki-
ase (JNK/SAPK) (16, 17) and the p38 MAPK (18, 19).
hile the functional consequences of CD40 activation
f these MAPKs remain to be fully resolved a recent









































































Vol. 289, No. 1, 2001 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONShe CD40-induced proliferation of B cells and its induc-
ion of genes such as ICAM-1 (20). Interestingly, the
ame report also described a lack of involvement of p38
n mediating the CD40 induction of a wide range of
ther proteins including CD40 itself, CD95/Fas, cIAP2,
RAF1, TRAF4, and DR3 and thus concluded that
D40 induces gene expression via both p38 MAPK-
ependent and independent pathways. This prompted
he present investigation into whether p38 is employed
y CD40 in mediating one of its most important bio-
ogical effects in B cells, namely its induction of Ce
ermline transcripts which acts as the key determining
tep in IgE isotype switching.
The study exploited the specific cell-permeable p38
APK inhibitor SB203580 (21) and a dominant nega-
ive form of p38 MAPK to show that p38 is crucially
nvolved in mediating the CD40 activation of the Ce
romoter which regulates induction of Ce germline
ranscripts. The results also suggest that p38 contrib-
tes to the activation of the promoter by increasing the
ransactivation potential of NF-kB. The study thus
oncludes that p38 MAPK is a crucial player in IgE
sotype switching and may represent a valuable tar-
et in controlling unwanted IgE synthesis in allergic
eactions.
ATERIALS AND METHODS
Materials. RPMI 1640 and FCS were from Life Technologies,
nc. (Paisley, UK). Glutamine, streptomycin, and HAT medium (100
FIG. 1. Activation of Ce promoter by IL-4 and engagement of
D40 in BJAB B cells. BJAB cells (1 3 107 cells) were electroporated
ith e-luc (10 mg), a plasmid encoding a luciferase reporter gene
egulated by the Ce promoter. Electroporated cells were subse-
uently treated for 24 h in the absence (Con) and presence of IL-4
100 U/ml) and/or an anti-CD40 antibody (500 ng/ml) adsorbed onto
D32-transfected fibroblasts. Cell extracts were measured for lucif-
rase activity and the results are expressed as fold induction of
uciferase relative to cells which were treated in the absence of IL-1
nd anti-CD40 antibody. The data represent mean 1/2 SEM of four
ndependent experiments.277igma (Poole, UK). IL-4 was from R & D (Oxon, UK). Luciferase
ubstrate and lysis buffer were from Promega Corp. (Madison, WI).
he PhosphoPlus p38 MAP Kinase antibody kit was from New En-
land Biolabs (Beverly, MA). SB203580 was from Calbiochem-
ovabiochem Ltd. (Nottingham, UK). The EBV negative human B
ell lymphoma cell line was a gift from Dr. D. Walls, Dublin City
niversity, Ireland. CD32-transfected fibroblasts (ATCC No. CRL-
0680) and the anti-CD40 antibody are previously described (22).
he e-luciferase reporter plasmid (e-luc) consists of the germline Ce
romoter (the region 2162/153 relative to the first initiation site for
ermline e-transcripts) ligated upstream of the luciferase reporter
ene and was a gift from Professor J. Stavnezer (University of
assachusetts Medical School, MA). The NFkB-luciferase reporter
lasmid (kB-luc) consists of five copies of the NFkB consensus site
loned into the luciferase reporter construct pGL3-Basic (Promega
orporation). The plasmid encoding dominant negative p38 MAPK
as a gift from Professor R. J. Davis (University of Massachusetts
edical Center, MA) and has been described previously (23).
EGFP-N1 (in which EGFP stands for enhanced green fluorescent
rotein) was from Clontech Laboratories (Palo Alto, CA).
Cell culture. Human BJAB cells were cultured in RPMI 1640
edium supplemented with 10% FCS, 2 mM L-glutamine, 100 U/ml
enicillin, and 100 mg/ml streptomycin. CD32-transfected fibroblasts
ATCC No. CRL-10680) were cultured in RPMI 1640 supplemented
FIG. 2. Engagement of CD40 activates p38 MAPK in BJAB cells.
JAB cells (1 3 107 cells) were treated for 30 min in the absence and
resence of IL-4 (100 U/ml) and/or an anti-CD40 antibody (500
g/ml) adsorbed onto CD32-transfected fibroblasts. Cell lysates were
repared and analysed by Western immunoblotting for levels of (A)
hosphorylated p38 MAPK and (B) total p38 MAPK using the Phos-
hoPlus p38 MAP kinase antibody kit (New England Biolabs). Im-
unoreactivity was visualised by enhanced chemiluminesence and
and intensity quantitated by densitometric scanning on a Molecular
ynamics 300S computing densitometer (Sunnyvale, CA) using Im-
geQuant V3.0 software. The numbers under each lane represent the
and intensity relative to the intensity of the band in cells which had
een treated in the absence of IL-4 and anti-CD40.
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278treptomycin, and HAT medium supplement. Both cell types were
rown in a humidified atmosphere of 5% CO2 at 37°C.
Transfection of BJAB cells and assay of expression of luciferase
eporter genes. Aliquots (250 ml) of BJAB cells (4 3 107 cells/ml)
ere electroporated (220 V, 960 mF) with e-luc (10 mg) or kB-luc (5
g) in RPMI 1640 medium supplemented with 10% FCS, 2 mM
-glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin by
eans of a Bio-Rad Gene Pulser equipped with a capacitance ex-
ender (Bio-Rad, Hercules, CA). In some experiments BJAB cells
ere cotransfected with 15 mg of the expression vector encoding
ominant negative p38 MAPK, 5 mg of pEGFP-N1 and e-luc (10 mg)
r kB-luc (5 mg). The electroporated cells were subsequently added to
resh medium (5 ml) and allowed to recover for 24 h in a humidified
tmosphere of 5% CO2 at 37°C. Aliquots (2.5 ml) of recovered cells
ere incubated in the absence or presence of SB203580 (10 mM) for
h prior to stimulation with or without anti-CD40 monoclonal an-
ibody (500 ng/ml) and recombinant human IL-4 (100 U/ml) for 5 min
t room temperature. Cells were subsequently mixed with aliquots
750 ml; 4 3 105 cells/ml) of CD32-transfected fibroblasts and aliquots
250 ml) of the mixed BJAB/fibroblast suspension then seeded into
6-well plates and incubated at 37°C for a further 24 h. Cells extracts
ere then generated and measured for luciferase activity using the
uciferase Assay System with Reporter Lysis buffer from Promega
orporation. Transfection efficiency was measured by counting the
umber of cells expressing the EGFP fluorescent protein using flow
ytometry as described previously (24).
Western blot analysis of p38 phosphorylation. Aliquots (2.5 ml) of
ntransfected BJAB cells (4 3 106 cells/ml) were stimulated for 30
in in the absence or presence of anti-CD40 monoclonal antibody
nd IL-4, as described above. Stimulation was terminated by centri-
uging the cells at 1450g for 5 min and washing the cell pellet once in
BS (1 ml). The cells were then lysed in SDS–PAGE sample buffer
100 ml) (50 mM Tris–HCl buffer, pH 6.8 containing 2% (w/v) SDS,
0% glycerol, 1% (v/v) 2-mercaptoethanol and 0.1% bromophenol
lue). The lysates were sonicated for 10 s to reduce sample viscosity
nd then heated to 90°C for 5 min. Lysates were cleared of particu-
ate material by centrifugation at 20,000g for 5 min. Aliqouts (25 ml)
f the clear supernatants were subjected to SDS–PAGE on 12%
olyacrylamide slab gels and the separated proteins electrophoreti-
ally transferred from the gels to nitrocellulose. The nitrocellulose
as then probed for levels of phosphorylated and total p38 using the
hosphoPlus p38 MAP Kinase (Thr180/Tyr182) antibody kit as
ecommended by the manufacturers (New England Biolabs). Immu-
oreactivity was visualised by enhanced chemiluminesence. Densi-
ometric scanning of enhanced chemiluminescence blots was per-
ormed on a Molecular Dynamics 300S computing densitometer
Sunnyvale, CA) using ImageQuant V3.0 software.
Statistical analysis. Significance was evaluated by Student’s t
est for unpaired data.
ESULTS AND DISCUSSION
The overall objective of this study was to explore the
otential role of p38 in IgE isotype switching in B
ogether with a pEGFP-N1 plasmid encoding constitutively ex-
ressed EGFP (5 mg of DNA) and e-luc (10 mg). Electroporated cells
ere subsequently incubated for 24 h as above in the absence and
resence of IL-4 and anti-CD40. All cell extracts were measured for
uciferase activity and the results are expressed as fold induction of
uciferase relative to control cells which were treated in the absence
f IL-4 and anti-CD40 antibody. The data represent mean 1/2 SEM
f four independent experiments. Significantly different (*P , 0.05,
*P , 0.01, ***P , 0.001) when compared to control values.FIG. 3. SB203580 and dominant negative p38 MAPK inhibit
D40 activation of Ce promoter. (A) BJAB cells (1 3 107 cells) were
lectroporated with e-luc (10 mg), a plasmid encoding a luciferase
eporter gene regulated by the Ce promoter. Electroporated cells
ere treated with and without SB203580 (10 mM) for 1 h and sub-
equently stimulated for 24 h in the absence (Con) and presence
IL-41CD40) of IL-4 (100 U/ml) and anti-CD40 antibody (500 ng/ml).
B) BJAB cells (1 3 107 cells) were cotransfected by electropora-
ion with an empty expression vector (15 mg of DNA) or the same
mount of expression vector encoding dominant negative p38 MAPK,
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279cripts is the key step in initiating IgE switching this
rompted an investigation into the importance of p38
n regulating this induction process. However, it was
ecessary to initially establish a suitable model system
or investigation. The EBV negative B cell lymphoma
JAB cell line was used as the model human B cell
ystem. The process of IgE switching requires the dual
ignals of IL-4 and activation of CD40 and this was
chieved by treating the BJAB cells with exogenous
uman recombinant IL-4 and an agonistic anti-CD40
ntibody adsorbed onto CD32-trasfected fibroblasts.
he latter has been shown to be an effective means of
ross-linking and activating CD40 (22). BJAB cells
ere initially examined for their responsiveness to
timulation by IL-4 and CD40 with respect to activa-
ion of the promoter controlling expression of the Ce
ermline transcripts. The activity of the Ce promoter
as determined by measuring the expression of a
ransfected luciferase gene ligated downstream of the
e promoter (e-luc) (8). BJAB cells, in the absence of
timulation by IL-4 and CD40, displayed basal expres-
ion of luciferase and any induction above this level is
isplayed as fold induction. BJAB cells showed some
asal activation of the Ce promoter but e-luc expression
as increased approximately twofold by stimulating
he cells alone with either IL-4 or CD40 (Fig. 1). The
ombination of both stimuli caused a synergistic sixfold
nduction of luciferase. Such synergistic activation of
he Ce promoter by IL-4 and CD40 is consistent with a
revious report (8) and is explained by the concerted
inding of STAT-6 and NF-kB to the Ce promoter (7–9).
hese findings further validate a previous report which
romoted the BJAB cell line as a valuable model sys-
em for exploring the regulation of expression of germ-
ine Ce transcripts (25). Thus BJAB cells and the e-luc
eporter system were employed as a suitable paradigm
o explore the role of p38 in mediating the induction of
e germline transcripts in B cells. However prior to
uch an exploration it was necessary to show that
D40 could activate p38 in BJAB cells.
BJAB cells were stimulated in the presence and ab-
ence of IL-4 and agonistic anti-CD40 antibody and
ubsequently examined for activation of the p38 path-
ay. This was judged by probing the cells for immuno-
eactivity with an antibody which detects doubly phos-
horylated threonine 180 and tyrosine 182 of p38
APK. Western immunoblotting demonstrated that
ells in the absence of stimulation by IL-4 and CD40,
L-4 and anti-CD40. All cell extracts were measured for luciferase
ctivity and the results are expressed as fold induction of luciferase
elative to control cells which were treated in the absence of IL-4 and
nti-CD40 antibody. The data represent mean 1/2 SEM of four
ndependent experiments. Significantly different (*P , 0.05) when
ompared to control values.FIG. 4. SB203580 and dominant negative p38 MAPK inhibit
D40 induction of NFkB-regulated reporter gene. (A) BJAB cells
1 3 107 cells) were electroporated with kB-luc (5 mg), a plasmid
ncoding a luciferase reporter gene regulated by a promoter contain-
ng five copies of the NFkB consensus site. Electroporated cells were
reated with and without SB203580 (10 mM) for 1 h and subse-
uently stimulated for 24 h in the absence (Con) and presence (IL-
1CD40) of IL-4 (100 U/ml) and anti-CD40 antibody (500 ng/ml). (B)
JAB cells (1 3 107 cells) were cotransfected by electroporation with
n empty expression vector (15 mg of DNA) or the same amount of
xpression vector encoding dominant negative p38 MAPK, together
ith a pEGFP-N1 plasmid encoding constitutively expressed EGFP
5 mg of DNA) and kB-luc (5 mg). Electroporated cells were subse-
uently incubated for 24 h as above in the absence and presence of




















































































Vol. 289, No. 1, 2001 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONShich reacted with the antibody indicative of some
asal levels of phosphorylated p38 MAPK in BJAB
ells (Fig. 2A). The engagement of CD40 alone was
ufficient to at least double the intensity of the band
hus demonstrating that CD40 can activate the p38
APK pathway in BJAB cells. The addition of IL-4
ailed to affect the degree of basal or CD40 induced
hosphorylation of p38 indicating that it does not con-
ribute to the activation of the p38 MAPK pathway in
cells. As control for the assay, all samples showed
quivalent levels of total p38 as judged by Western
mmunoblotting analysis using control antibodies
hich recognise p38 irrespective of its phosphorylation
tatus (Fig. 2B). The ability of CD40 engagement to
ctivate the p38 MAPK pathway in B cells confirms
imilar previous findings (18–20). The lack of effect of
L-4 on p38 is not surprising since its primary role is to
ctivate the transcription factor STAT-6 via the unre-
ated JAK-3 kinase (26).
The demonstration that CD40 activates p38 in BJAB
ells allowed for the exploration of the contribution of
his pathway to mediating CD40 induction of Ce germ-
ine transcripts. This was achieved by initially evalu-
ting the inhibitory effects of SB203580, the p38
APK inhibitor, on the activity of the Ce promoter, as
udged by expression of the e-luc reporter gene (Fig.
A). SB203580 reduced the basal expression of e-luc
nd inhibited by over 50% the ability of CD40 to induce
-luc. This indicates a key role for p38 in mediating the
D40 induction of Ce germline transcripts, the pro-
ogue to IgE switching. This was further confirmed by
robing the effect of cotransfected dominant negative
38 MAPK on the activity of the Ce promoter (Fig. 3B).
ike SB203580, dominant negative p38 MAPK mark-
dly reduced the basal and CD40-induced expression of
-luc, confirming the crucial role of p38 MAPK in me-
iating the activation of the Ce promoter by CD40.
ominant negative p38 MAPK had no effect on trans-
ection efficiency since cells transfected with dominant
egative p38 and control cells transfected with an
mpty expression vector displayed comparable trans-
ection efficiencies of 12%. The clear role of p38 in
ediating the CD40 activation of the Ce promoter
rompted an investigation into the underlying mecha-
ism. The unequivocal importance of NFkB in the
D40 signaling pathway leading to IgE swithing (8, 9,
1, 14) coupled to recent reports describing a role for
38 in regulating the transactivation potential of
FkB (20, 27) warranted an analysis of the involve-
ent of p38 in modulating the activity of NFkB in the
resent experimental system.
The activity of NFkB in the BJAB cells was deter-
ined by measuring the induction of a transfected
FkB-regulated luciferase gene (kB-luc) (Fig. 4). The
timulation of CD40 in BJAB cells was sufficient to
nduce an approximate twofold induction of luciferase.280educed the ability of CD40 to induce kB-luc indicating
n important role for p38 in mediating the CD40 acti-
ation of NFkB (Fig. 4A). This was further confirmed
y the equally impressive inhibitory effects of cotrans-
ected dominant negative p38 MAPK on the induction
f kB-luc by CD40 (Fig. 4B). Since SB203580 fails to
ffect the ability of CD40 to effect nuclear translocation
nd DNA-binding of NFkB in BJAB cells (data not
hown) these findings suggest that the CD40 activation
f p38 facilitates increased NFkB activity by improving
ts transactivation potential. This confirms a recent
eport which proposes a similar mechanism by which
D40 activates NFkB and thus induces B cell prolifer-
tion (20).
In summary, the present study thus proposes that
D40 activates p38 MAPK in B cells which in turn
ncreases the ability of nuclear translocated NFkB to
ctivate the Ce promoter and induce Ce germline tran-
cripts. This ultimately promotes IgE isotype switch-
ng and thus p38 is a major player in facilitating IgE
ynthesis. Such findings promote p38 as a novel target
o exploit in the development of new therapeutic re-
imes to counter the production of IgE in allergy-based
iseases.
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